These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 10566049

  • 21. Clinical potential of emerging antiarrhythmic agents.
    Capucci A, Aschieri D, Villani GQ, Piepoli MF.
    Drugs R D; 1999 Apr; 1(4):279-90. PubMed ID: 10566046
    [Abstract] [Full Text] [Related]

  • 22. Guidelines for the use of propafenone in treating supraventricular arrhythmias.
    Kishore AG, Camm AJ.
    Drugs; 1995 Aug; 50(2):250-62. PubMed ID: 8521758
    [Abstract] [Full Text] [Related]

  • 23. Perspectives on the current treatment of cardiac arrhythmias.
    Bigger JT.
    Am J Cardiol; 1984 Aug 13; 54(4):2B-7B. PubMed ID: 6147081
    [Abstract] [Full Text] [Related]

  • 24. [Pharmaco-toxicologic evaluation of newly synthesized analogs of propafenone].
    Tumová I, Racanská E, Csöllei J, Ecker G, Otrusník R, Svec P.
    Ceska Slov Farm; 1997 Jun 13; 46(3):133-6. PubMed ID: 9440950
    [Abstract] [Full Text] [Related]

  • 25. The differentiation of propafenone from other class Ic agents, focusing on the effect on ventricular response rate attributable to its beta-blocking action.
    Faber TS, Camm AJ.
    Eur J Clin Pharmacol; 1996 Jun 13; 51(3-4):199-208. PubMed ID: 9010685
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacology of antiarrhythmic drugs in elderly patients.
    Frishman WH, Aronow WS.
    Clin Geriatr Med; 2012 Nov 13; 28(4):575-615. PubMed ID: 23101572
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hot topics in cellular cardiac electrophysiology with potential impact on future drug design.
    Nánási PP, Kecskeméti V.
    Curr Med Chem; 2011 Nov 13; 18(24):3595-6. PubMed ID: 21774766
    [No Abstract] [Full Text] [Related]

  • 33. [Electrophysiologic and hemodynamic effects of the new anti-arrhythmia agent diprafenone].
    Gülker H, Heuer H, Thale J, Behrenbeck T.
    Z Kardiol; 1987 Jul 13; 76(7):411-4. PubMed ID: 3673162
    [Abstract] [Full Text] [Related]

  • 34. Clinical pharmacology of antiarrhythmic drugs.
    Capucci A, Aschieri D, Villani GQ.
    Drugs Aging; 1998 Jul 13; 13(1):51-70. PubMed ID: 9679209
    [Abstract] [Full Text] [Related]

  • 35. Propafenone for cardiac arrhythmias.
    Birgersdotter-Green U.
    Am J Med Sci; 1992 Feb 13; 303(2):123-8. PubMed ID: 1539611
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Propafenone in the treatment of cardiac arrhythmias].
    Podzolkov VI, Tarzimanova AI.
    Kardiologiia; 2012 Feb 13; 52(5):70-3. PubMed ID: 22839589
    [No Abstract] [Full Text] [Related]

  • 40. Drugs for cardiac arrhythmias.
    Med Lett Drugs Ther; 1991 Jun 14; 33(846):55-60. PubMed ID: 1674978
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.